How big is AN2 Therapeutics, Inc.?

Jun 22 2025 06:17 PM IST
share
Share Via
As of Jun 18, AN2 Therapeutics, Inc. has a market capitalization of 35.61 million and reported net sales of 0.00 million with a net profit of -45.36 million over the last four quarters. As of Dec 24, the company's shareholder's funds were 81.85 million, and total assets were 92.09 million.
As of Jun 18, AN2 Therapeutics, Inc. has a market capitalization of 35.61 million, categorizing it as a Micro Cap company.

As of Jun 18, the company reported net sales of 0.00 million for the latest four quarters, with a consolidated net profit of -45.36 million during the same period.

As of Dec 24, the company's shareholder's funds were 81.85 million, and total assets amounted to 92.09 million.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is AN2 Therapeutics, Inc. technically bullish or bearish?
Sep 20 2025 08:07 PM IST
share
Share Via
Is AN2 Therapeutics, Inc. technically bullish or bearish?
Jun 25 2025 09:06 AM IST
share
Share Via
What does AN2 Therapeutics, Inc. do?
Jun 22 2025 07:05 PM IST
share
Share Via